Cargando…
Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome
BACKGROUND: Natural history studies are increasingly recognized as having an important role in drug development for rare diseases. A phase 3, observational, retrospective, and non-interventional study was designed to establish a natural history control (NHC) cohort of patients with Barth syndrome (B...
Autores principales: | Hornby, Brittany, Thompson, William Reid, Almuqbil, Mohammed, Manuel, Ryan, Abbruscato, Anthony, Carr, Jim, Vernon, Hilary J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438322/ https://www.ncbi.nlm.nih.gov/pubmed/36056411 http://dx.doi.org/10.1186/s13023-022-02469-5 |
Ejemplares similares
-
Identifying responders to elamipretide in Barth syndrome: Hierarchical clustering for time series data
por: Van den Eynde, Jef, et al.
Publicado: (2023) -
A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism
por: Reid Thompson, W., et al.
Publicado: (2020) -
Quality of life in Barth syndrome
por: Kim, Alexander Y., et al.
Publicado: (2022) -
Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide
por: Sabbah, Hani N.
Publicado: (2020) -
Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid
por: Sabbah, Hani N.
Publicado: (2021)